1. Efficacy and Safety of Once-Daily Regimens in the Treatment of HIV Infection

   • Jean-Michel Molina

   Current Opinion 17 September 2012 Pages: 567 - 578

   

2. β-Blockers and Coronary Flow Reserve

   • Maurizio Galderisi
   • Arcangelo D’Errico

   Current Opinion 17 September 2012 Pages: 579 - 550

   

3. Rheumatoid Arthritis

   • Joseph R. Lutt
   • Atul Deodhar

   Therapy in Practice 17 September 2012 Pages: 591 - 606

   

4. Effect of Drugs on Defibrillation Capacity

   • Anna Legreid Dopp
   • John M. Miller
   • James E. Tisdale

   Review Article 17 September 2012 Pages: 607 - 630

   

5. Temsirolimus

   • Dene Simpson
   • Monique P. Curran

   Adis Drug Profile 17 September 2012 Pages: 631 - 638

   

6. Dalbavancin

   • Vanessa R. Anderson
   • Gillian M. Keating

   Adis Drug Profile 17 September 2012 Pages: 639 - 648

   

7. Dalbavancin

   • Eric S. Schweiger

   Adis Drug Profile 17 September 2012 Pages: 649 - 649

8. Dalbavancin

   • William J. Peppard

   Adis Drug Profile 17 September 2012 Pages: 649 - 649

9. Dalbavancin

   • Lawrence Eron

   Adis Drug Profile 17 September 2012 Pages: 649 - 649

10. Dalbavancin

    • Peggy L. Carver

    Adis Drug Profiles 17 September 2012 Pages: 649 - 651

11. Bupropion

    • Sohita Dhillon
    • Lily P. H. Yang
    • Monique P. Curran

    Adis Drug Evaluation 17 September 2012 Pages: 653 - 689

    

12. Enoxaparin

    • Natalie J. Carter
    • Paul L. McCormack
    • Greg L. Plosker

    Adis Drug Evaluation 17 September 2012 Pages: 691 - 710

    

13. Lanreotide Autogel®

    • Jamie D. Croxtall
    • Lesley J. Scott

    Adis Drug Evaluation 17 September 2012 Pages: 711 - 723

    

14. Lanreotide Autogel® in the Management of Acromegaly

    • Mark E. Molitch

    Commentary 17 September 2012 Pages: 724 - 724